(Q57269736)

https://api.crossref.org/works/10.1007%2FS00436-011-2315-6

Development of a vaccine for toxoplasmosis: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2315-6

Pichia pastoris as a host system for transformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2315-6

Recent advances in the expression of foreign genes in Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2315-6

Review: methylotrophic yeasts as factories for the production of foreign proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2315-6

Toxoplasma gondii: the role of parasite surface and secreted proteins in host cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2315-6

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2315-6

Toxoplasma gondii: Serological characterization and immunogenicity of recombinant surface antigen 2 (SAG2) expressed in the yeast Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2315-6

Modified protection against Toxoplasma gondii lethal infection and brain cyst formation by vaccination with SAG2 and SRS1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2315-6

Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2315-6

Usefulness of Toxoplasma gondii recombinant antigens (GRA1, GRA7 and SAG1) in an immunoglobulin G avidity test for the serodiagnosis of toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2315-6

Cloning, expression, and cDNA sequence of surface antigen P22 from Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2315-6

Immunity to Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2315-6

Interferon-gamma: the major mediator of resistance against Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2315-6

Parasitic diseases and immunodeficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2315-6

Protective immunity against Toxoplasma gondii in mice induced by a chimeric protein rSAG1/2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-011-2315-6

Expression, characterization, and serologic reactivity of recombinant surface antigen P22 of Toxoplasma gondii.

21 January 2018

1 reference

12 December 2020

Isotypic profiles of antibody responses to Toxoplasma gondii infection in rats and mice: kinetic study and characterization of target antigens of immunoglobulin A antibodies

1 reference

12 December 2020

Murine CD8+ cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells.

1 reference

12 December 2020

Characterization of Toxoplasma gondii surface antigen 1 (SAG1) secreted from Pichia pastoris: evidence of hyper O-glycosylation

1 reference

12 December 2020

Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine

1 reference

12 December 2020

Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii.

1 reference

12 December 2020

Glycosylation of Pichia pastoris-derived proteins.

1 reference

12 December 2020

Cellular immune responses to recombinant antigens in pregnant women chronically infected with Toxoplasma gondii.

1 reference

12 December 2020

Serodiagnosis of recently acquired Toxoplasma gondii infection using an enzyme-linked immunosorbent assay with a combination of recombinant antigens

1 reference

12 December 2020

Attachment of Toxoplasma gondii to host cells involves major surface protein, SAG-1 (P30)

1 reference

12 December 2020

Protective immunity against Toxoplasma gondii in mice induced by the SAG2 internal image of anti-idiotype antibody

1 reference

12 December 2020

Recombinant antigens to detect Toxoplasma gondii-specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunoassay

1 reference

12 December 2020

A purified parasite antigen (p30) mediates CD8+ T cell immunity against fatal Toxoplasma gondii infection in mice

1 reference

12 December 2020

Seroreactivity to and avidity for recombinant antigens in toxoplasmosis

1 reference

12 December 2020

Surface antigens of Toxoplasma gondii

1 reference

12 December 2020

Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-alpha.

1 reference

12 December 2020

The conformation of purified Toxoplasma gondii SAG1 antigen, secreted from engineered Pichia pastoris, is adequate for serorecognition and cell proliferation

1 reference

12 December 2020

Toxoplasma gondii: expression and characterization of a recombinant protein containing SAG1 and GRA2 in Pichia pastoris

1 reference

12 December 2020

Western Blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies

1 reference

12 December 2020